Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Syndrome and Associated Gait Changes in Post-menopausal Women

Launched by LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER SHREVEPORT · Sep 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how effective a treatment called transcutaneous tibial nerve stimulation is for women aged 60 and older who experience overactive bladder syndrome, which can cause frequent urges to urinate and leakage, especially at night. The researchers want to find out how many treatment sessions are needed each week over a 12-week period to improve bladder symptoms, increase confidence in preventing falls, and see if the way participants walk changes after treatment. Participants will visit the clinic three times, complete questionnaires, and take part in walking tasks to assess their bladder control and mobility.

To be eligible for this trial, women must be over 60 years old and have a specific score indicating significant bladder issues. They cannot have certain conditions like stress urinary incontinence, active urinary tract infections, or be on specific bladder medications. During the trial, participants will receive the stimulation treatment either 2 or 4 times a week for three months, and will keep a diary of their bladder habits. This trial not only aims to improve bladder symptoms but also to help enhance mobility and confidence in daily activities.

Gender

FEMALE

Eligibility criteria

• • Inclusion Criteria: Inclusion criteria include females over 60 years of age who score an 8 or greater on the OAB-V8 with no exclusion criteria.
• • -
• • Exclusion Criteria: those who experience stress UI only, have a pacemaker, neurologic deficit (e.g. Parkinson\'s disease, multiple sclerosis, spinal cord injury), current urinary tract infection, known active cancer, or current OAB medication use (Tolterdine, etc.) with consideration of a washout period, and inability to walk 30 meters.
• • -